Ethyl 3,5-dimethyl-1H-pyrazole-4-carboxylate, 95.0%, 10g

4-Amino-3-fluorobenzoic Acid>98.0%(HPLC)(T)1g

(2-Nitroethyl)benzene, 95.0%, 5g

1-(2-Bromoethoxy)-4-(tert-butyl)benzene, 98%, 250mg

6-(trifluoromethyl)-2H,3H-[1,3]thiazolo[4,5-b]pyridine-2-thione, 98%, 1g

4-Bromo-1,5-dimethyl-1H-pyrazole-3-carboxylic acid, 95.0%, 25g

(S)-4-Formyl-2,2-dimethyl-oxazolidine-3-carboxylic tert-butyl ester, 98.0%, 1g

Colonne capillaire GC ROTI®Cap-1 MS, 15 m, 0,25 mm, 0,25 µm, 1 pièce(s)

1-(3-(Difluoromethyl)-1-methyl-1H-pyrazol-4-yl)ethan-1-one, 97%, 1g

4-(2-Bromophenyl)pyridine>98.0%(GC)(T)200mg

1-(2-Chloro-4-fluoro-benzyl)-3-isothiocyanato-1H-pyrazole, 250mg

Dibenzo[b,d]furan-2-ylboronic acid, 95.0%, 5g

3-(4-fluoro-3-methoxyphenyl)propanoic acid, 95.0%, 250mg